Tissue-Based Diagnostics Market to Reach USD 13.85 Billion by 2034 Amid Rising Precision Medicine Adoption – SRI
Publish Date: 2026-07-03 06:06:00
Source Domain: industrytoday.co.uk
The Tissue-Based Diagnostics market was valued at $6.22 billion in 2025 and is projected to reach $13.85 billion by 2034, growing at a CAGR of 9.3% during the forecast period 2026-2034.
London, UK – July 2026 | Strategic Revenue Insights Inc. – The Tissue-Based Diagnostics market was valued at $6.22 billion in 2025 and is projected to reach $13.85 billion by 2034, growing at a CAGR of 9.3% during the forecast period 2026-2034. Growth is driven by rising cancer prevalence and increasing demand for precise diagnostic tools.
Tissue-based diagnostics provide detailed insights into disease pathology through techniques such as immunohistochemistry, in situ hybridization, and digital pathology. Technological advancements in these methods are improving diagnostic accuracy and efficiency, supporting broader adoption across hospitals, laboratories, and research institutions worldwide.
Rising incidence of chronic diseases, particularly cancer, is expanding healthcare infrastructure investment globally. Emerging economies are modernizing diagnostic capabilities to meet growing patient demand, creating substantial opportunities for tissue-based diagnostic adoption as healthcare systems prioritize early and accurate disease detection.
A comprehensive assessment of this rapidly evolving market can be accessed through Strategic Revenue Insights at the link below, focused on Tissue-Based Diagnostics:
https://www.strategicrevenueinsights.com/industry/tissue-based-diagnostics-market
Growing emphasis on personalized medicine is increasing demand for precise diagnostic tools capable of guiding individualized treatment plans. Tissue-based diagnostics provide comprehensive pathology data that supports companion diagnostics, enabling healthcare providers to match patients with the most effective targeted therapies available.
Integration of artificial intelligence and machine learning into digital pathology is transforming diagnostic…
